期刊文献+

乙肝血清学标志物HBeAg与HBeAb共存模式分析 被引量:7

Analysis on coexistence of HBeAg and HBeAb in serum HBV markers
下载PDF
导出
摘要 目的了解乙肝血清学标志物(HBV-M)检测中乙肝病毒e抗原与抗体(HBeAg与HBeAb)同时阳性的特征。方法采用酶联免疫吸附法(ELISA)测定3118例各类乙型肝炎患者的HBV-M,对其中HBeAg与HBeAb同时阳性的样本进行双孔复检,如仍然为双阳性则采用中和实验验证。结果 3118例样本初检时检出HBeAg与HBeAb双阳性53例,经双孔复检仅剩31例显现双阳性,中和实验后确认双阳性样本19例。结论乙肝患者的血清当中HBeAg与HBeAb共存的模式客观存在,但必须慎重分析与复检。 Objective To study characteristics of coexistence of HBeAg and HBeAb in serum HBV markers.Methods By adopting ELISA immunity analysis technique,HBV markers were measured in 3118 sufferers with HBV,the positive samples of HBeAg and HBeAb were rechecked at the same time.If they were still positive,moderating experiment for verification was adopted.Results In 53 of 3 118 samples with positive results of HBeAg and HBeAb at previous examination,31 samples were still both positive after re-check examination.Nineteen samples of them were confirmed to be double positive by neutralization test.Conclusion HBeAg and HBeAb can really be coexisted in serum samples of hepatitis B sufferers,but careful analysis with re-check should be done.
出处 《临床和实验医学杂志》 2010年第12期895-896,共2页 Journal of Clinical and Experimental Medicine
关键词 乙肝E抗原 乙肝e抗体 免疫酶技术 Hepatitis B E antigen Immunoenzyme techniques
  • 相关文献

参考文献3

二级参考文献1

共引文献14018

同被引文献45

  • 1蒋雪花,孙永年,黄祝青,龚守军.干扰素治疗对慢性乙肝患者细胞因子和抗病毒疗效的影响分析[J].中国现代医学杂志,2004,14(24):76-78. 被引量:16
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 3王露楠,邓巍,张瑞,申子瑜,陈文祥,李金明.乙型肝炎表面抗原血清标准物质的研究[J].中华检验医学杂志,2007,30(8):858-862. 被引量:13
  • 4成军,孙长贵,陈瑜.乙型病毒性肝炎的实验窀诊断新进展[C].2010年浙江省检验医学学术年会沦文编,029-040.
  • 5中华医学会肝病学分会,中华医学会感染病学分会.慢性乙穗肝炎防治指南(2010年版)[J].中国肝脏病杂志(电子版),2011,3:40-56.
  • 6Sanchez MJ,Buti M,Homs M,et al. Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemo- therapy containing rituximab [ J ]. Hepatol, 2009,51 ( 6 ) : 1091.
  • 7Gouas D,Shi H,Hainaut P,et al. The aflatoxin - induced TP53 muta- tion at eodon 249 ( R249S ) : biomarker of exposure, early detection and target for therapy[J]. Cancer Lett,2009,286( 1 ) :29.
  • 8Tsai WL, C hung RT. Viral h epatocarcinogenesis [ J]. Oncogene,2010, 29(16) :2309.
  • 9Hadziyannis E, Manesis E, Vassilopoulos D, et al. Per- formance characteristics of microparticle enzyme and chemiluminescence immunoassays for measurement of an- ti-HBc immunoglobulin M in sera of patients with HBeAg-negative chronic hepatitis B virus infection[J]. Clin Vaccine Immunol, 2008,15 (2) : 385-387.
  • 10Huzly D,Schenk T,Jilg W,et al. Comparison of nine com- mercially available assays for quantification of antibody response to hepatitis B virus surface antigen[J]. J Clin Microbiol, 2008,46 (4) : 1298-1306.

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部